Phio Pharmaceuticals Corp. Quarterly Current Ratio in % from Q3 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Phio Pharmaceuticals Corp. quarterly Current Ratio history and growth rate from Q3 2012 to Q3 2024.
  • Phio Pharmaceuticals Corp. Current Ratio for the quarter ending September 30, 2024 was 513 %, a 7.51% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 513 +35.8 +7.51% Sep 30, 2024
Q2 2024 457 -94.8 -17.2% Jun 30, 2024
Q1 2024 494 -101 -17% Mar 31, 2024
Q4 2023 458 -252 -35.5% Dec 31, 2023
Q3 2023 477 -272 -36.3% Sep 30, 2023
Q2 2023 552 -285 -34% Jun 30, 2023
Q1 2023 595 -385 -39.3% Mar 31, 2023
Q4 2022 710 -419 -37.1% Dec 31, 2022
Q3 2022 749 -383 -33.8% Sep 30, 2022
Q2 2022 837 -221 -20.9% Jun 30, 2022
Q1 2022 980 -26.6 -2.64% Mar 31, 2022
Q4 2021 1.13K +330 +41.4% Dec 31, 2021
Q3 2021 1.13K +401 +54.8% Sep 30, 2021
Q2 2021 1.06K +416 +64.7% Jun 30, 2021
Q1 2021 1.01K +473 +88.6% Mar 31, 2021
Q4 2020 799 +244 +44% Dec 31, 2020
Q3 2020 731 +57.6 +8.56% Sep 30, 2020
Q2 2020 642 +48.7 +8.21% Jun 30, 2020
Q1 2020 534 +69.3 +14.9% Mar 31, 2020
Q4 2019 555 +253 +83.6% Dec 31, 2019
Q3 2019 674 +506 +301% Sep 30, 2019
Q2 2019 593 +414 +230% Jun 30, 2019
Q1 2019 464 +256 +123% Mar 31, 2019
Q4 2018 302 +9.78 +3.34% Dec 31, 2018
Q3 2018 168 -210 -55.6% Sep 30, 2018
Q2 2018 180 -218 -54.8% Jun 30, 2018
Q1 2018 208 -212 -50.4% Mar 31, 2018
Q4 2017 292 -156 -34.8% Dec 31, 2017
Q3 2017 378 -57.4 -13.2% Sep 30, 2017
Q2 2017 398 -166 -29.5% Jun 30, 2017
Q1 2017 421 -242 -36.6% Mar 31, 2017
Q4 2016 449 -170 -27.5% Dec 31, 2016
Q3 2016 436 -242 -35.8% Sep 30, 2016
Q2 2016 564 -141 -20% Jun 30, 2016
Q1 2016 663 -102 -13.3% Mar 31, 2016
Q4 2015 619 -279 -31.1% Dec 31, 2015
Q3 2015 678 -204 -23.1% Sep 30, 2015
Q2 2015 706 -240 -25.4% Jun 30, 2015
Q1 2015 765 -200 -20.8% Mar 31, 2015
Q4 2014 898 -96.5 -9.7% Dec 31, 2014
Q3 2014 882 -29.2 -3.2% Sep 30, 2014
Q2 2014 946 +191 +25.3% Jun 30, 2014
Q1 2014 965 +351 +57.1% Mar 31, 2014
Q4 2013 994 +680 +216% Dec 31, 2013
Q3 2013 911 +662 +266% Sep 30, 2013
Q2 2013 755 Jun 30, 2013
Q1 2013 614 Mar 31, 2013
Q4 2012 315 Dec 31, 2012
Q3 2012 249 Sep 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.